Embryonal rhabdomyosarcoma of the genitourinary organs

J. Fleischmann, E. P. Perinetti, W. J. Catalona

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


We report on 14 patients with embryonal rhabdomyosarcoma of the genitourinary organs treated with combined modality therapy. Six patients with paratesticular lesions are free of tumor 7 to 72 months (mean 44) after diagnosis, while 6 of 8 with pelvic lesions are free of tumor 18 to 132 months (mean 61) following diagnosis. Two patients died of metastases. Over-all, 2-year survival free of relapse was obtained in 9 of 11 patients (81 per cent). Of 4 patients with pelvic lesions who were treated with primary radiation-chemotherapy without exenteration 3 were managed successfully but 1 required urinary diversion for vesical fibrosis. Current concepts in the management of embryonal rhabdomyosarcoma are discussed.

Original languageEnglish (US)
Pages (from-to)389-391
Number of pages3
JournalJournal of Urology
Issue number3
StatePublished - 1981

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Embryonal rhabdomyosarcoma of the genitourinary organs'. Together they form a unique fingerprint.

Cite this